Literature DB >> 10361891

Ability of mosapride to bind to 5-HT4 receptor in the human stomach.

Y Sakurai-Yamashita1, K Takada, K Takemura, K Yamashita, A Enjoji, T Kanematsu, K Taniyama.   

Abstract

Ability of mosapride, a gastrokinetic agent, to bind to 5-HT4 receptor was examined in the stomach of human and guinea pig by in vitro receptor autoradiography. [125I]SB207710 binding sites were detected in the muscle layer including the myenteric plexus of the stomach from both humans and guinea pigs, although the binding was observed more clearly and densely in the stomach of guinea pigs than humans. Mosapride as well as SB204070 inhibited the binding of [125I]SB207710. Thus, mosapride possesses the ability to bind to 5-HT4 receptors of human stomach and may modulate the motility, as in the case of guinea pig stomach.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10361891     DOI： 10.1254/jjp.79.493

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN： 0021-5198


  6 in total

Review 1.  Pharmacology of serotonin: what a clinician should know.

Authors:  F De Ponti
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

2.  5-HT(4) receptors mediating enhancement of contractility in canine stomach; an in vitro and in vivo study.

Authors:  N H Prins; A van Der Grijn; R A Lefebvre; L M Akkermans; J A Schuurkes
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

Review 3.  New developments in the treatment of functional dyspepsia.

Authors:  Vincenzo Stanghellini; Fabrizio De Ponti; Roberto De Giorgio; Giovanni Barbara; Cesare Tosetti; Roberto Corinaldesi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Mosapride citrate improves postoperative ileus of patients with colectomy.

Authors:  Yoshitaka Toyomasu; Erito Mochiki; Hiroki Morita; Atsushi Ogawa; Mitsuhiro Yanai; Tetsuro Ohno; Takaaki Fujii; Soichi Tsutsumi; Takayuki Asao; Hiroyuki Kuwano
Journal:  J Gastrointest Surg       Date:  2011-05-24       Impact factor: 3.452

Review 5.  Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.

Authors:  F De Ponti; M Tonini
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  Impaired gastric motility and its relationship to reflux symptoms in patients with nonerosive gastroesophageal reflux disease.

Authors:  Takeshi Kamiya; Hiroshi Adachi; Makoto Hirako; Michiko Shikano; Eriko Matsuhisa; Tsuneya Wada; Naotaka Ogasawara; Shunsuke Nojiri; Hiromi Kataoka; Makoto Sasaki; Hirotaka Ohara; Takashi Joh
Journal:  J Gastroenterol       Date:  2009-02-13       Impact factor: 7.527
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.